Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats

Area of Science:

• Pharmacology
• Neuroscience
• Endocrinology

Background:

• Cognitive dysfunction is linked to inflammation, oxidative stress, and impaired insulin signaling in the hippocampus.
• Tau hyperphosphorylation is a key pathological feature contributing to cognitive decline.

Purpose of the Study:

• To investigate the effects of paeoniflorin on cognitive deficits in diabetic rats.
• To elucidate the underlying mechanisms of paeoniflorin's action.

Main Methods:

• Diabetic rat model induced by high-sucrose, high-fat diet and streptozotocin (STZ).
• Behavioral assessment using Morris water maze test.
• Immunohistochemistry to detect tau hyperphosphorylation, inflammatory cytokines (IL-1β, TNF-α), SOCS2, IRS-1, Akt, and GSK-3β.

Main Results:

• Paeoniflorin treatment improved spatial learning and memory in diabetic rats.
• Paeoniflorin reduced tau hyperphosphorylation and brain inflammation.
• Paeoniflorin modulated the SOCS2/IRS-1 pathway and promoted Akt/GSK-3β phosphorylation.

Conclusions:

• Paeoniflorin demonstrates beneficial effects against diabetes-associated cognitive deficits.
• The mechanism involves regulating the SOCS2/IRS-1 pathway and reducing neuroinflammation.
• Paeoniflorin presents a potential therapeutic strategy for cognitive dysfunction in diabetes.